US consumer groups are urging that a popular diabetes drug, which they claim damages the liver and has caused 26 deaths, should be banned by the US government. The drug regulatory body, the US Food and Drug Administration (FDA), is planning to upgrade its warnings to doctors over the drug, Rezulin, encouraging them to monitor patients for signs of liver damage.